Enhanced potency of prasugrel on protease-activated receptors following bivalirudin treatment for PCI as compared to clopidogrel.
Enhanced potency of prasugrel on protease-activated receptors following bivalirudin treatment for PCI as compared to clopidogrel.
复制标题
与氯吡格雷相比，比伐卢定治疗 PCI 后普拉格雷对蛋白酶激活受体的效力增强。
DOI：
10.1016/j.thromres.2019.01.017
复制
发表时间：
2019
影响因子：
7.5
通讯作者：
Covic,Lidija
中科院分区：
文献类型：
--
作者：
Kimmelstiel,Carey;Stevenson,Ryan;Nguyen,Nga;VanDoren,Layla;Zhang,Ping;Perkins,James;Kapur,NavinK;Weintraub,Andrew;Castaneda,Vilma;Kuliopulos,Athan;Covic,Lidija
